Status epidermis in introduktion of the drug «radiesse» and «luminaire»
Abstract
About the Authors
G. M. MogilnayaRussian Federation
E. V. Fomicheva
Russian Federation
Yu. E. Blatt
Russian Federation
References
1. Beer K., John M.,Cohen J. Evaluation of injectable CaHA for the treatment of mide-face volume loss // J. drugs dermatol. -2008. - V. 7 (4). - P. 359-366
2. Lizzul P., Narurkar V. The role of calcium hidroxylapatite (Radiesse) in nonsurgical aesthetic rejuvenation // J. drugs dermatol. - 2010. - V. 9 (5). - P. 446-450.
3. Jacovella P. Use ofcalcium hidroxylapatite (radiesse) for facial augmentation. Clinical interventions in aging. - 2008. - P. 161-174; Hevia O. Correction of lowerface with calcium hydroxylapatite // Dermatol. surg. - 2009. - V. 35. - P. 1487-1494.
4. Busso M., Moers-Carpi M., Storck R., Ogilvie P., Ogilvie A. Multicenter, randomized trial assessing the effectiveness and safety of calcium hydroxylapatite for hand rejuvenation // Dermatol. surg. - 2010. - V. 36. - P. 790-797.
5. Marmur E., Phelps R., Goldberg D. Clinical, histologic and electron microscopic findings after injection of a calciumhydroxylapatite filler // J. cosmet. laser ther. - 2004. -V. 6. - P. 223-226.
6. Pearce A. Histochemistry. Theoretical and applied. -London, 1968. - 561 p.
Review
For citations:
Mogilnaya G.M., Fomicheva E.V., Blatt Yu.E. Status epidermis in introduktion of the drug «radiesse» and «luminaire». Kuban Scientific Medical Bulletin. 2015;(4):93-96. (In Russ.)